Marker rhythms of circadian system function: A study of patients with metastatic colorectal cancer and good performance status

Chronobiology International

Volumn 19, Issue 1, 2002, Pages 141-155

  Mormont, Marie Christine ^a   Langouët, Anne Marie ^a   Claustrat, Bruno ^b   Bogdan, André ^c   Marion, Sylvie ^a   Waterhouse, Jim ^d   Touitou, Yvan ^c   Lévi, Francis ^a  

^a INSERM   (France)

^b HÔPITAL NEUROLOGIQUE   (France)

^c PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^d LIVERPOOL JOHN MOORES UNIVERSITY   (United Kingdom)

Author keywords

Circadian clock; Cortisol; Melatonin; Rest activity cycle; White blood cells

Indexed keywords

ARTICLE; BLOOD SAMPLING; CANCER PATIENT; CELL PROLIFERATION; CIRCADIAN RHYTHM; COLORECTAL CANCER; CYTOKINESIS; FOOD INTAKE; HUMAN; HUMAN CELL; LYMPHOCYTE COUNT; METASTASIS POTENTIAL; MOLECULAR CLOCK; SLEEP WAKING CYCLE; TUMOR VOLUME;

ADULT; AGED; BIOLOGICAL MARKERS; CIRCADIAN RHYTHM; COLORECTAL NEOPLASMS; FEMALE; HUMANS; HYDROCORTISONE; KARNOFSKY PERFORMANCE STATUS; LYMPHOCYTE COUNT; MALE; MELATONIN; MIDDLE AGED; MOTOR ACTIVITY; SALIVA;

EID: 0036226048     PISSN: 07420528     EISSN: None     Source Type: Journal    
DOI: 10.1081/CBI-120002593     Document Type: Article

References (43)

1. Chronopharmacology of anticancer agents
2. Circadian timing of cancer chemotherapy
3. Chemotherapy of advanced ovarian cancer with 4′-O-tetrahydropyranyl doxorubicin and cisplatin. A randomized phase II trial with an evaluation of circadian timing and dose-intensity
4. A chronopharmacologic phase II clinical trial with 5-fluorouracil, folinic acid and oxaliplatin using an ambulatory multichannel programmable pump
5. Chronomodulated versus fixed-infusion-rate delivery of ambulatory chemotherapy with oxaliplatin, fluorouracil, and folinic acid in patients with colorectal cancer metastases. A randomized multi-institutional trial
6. A randomized multicenter trial of chronotherapy with oxaliplatin, 5-fluorouracil and leucovorin in ambulatory patients with metastases from colorectal cancer
7. For the International Organization for Cancer Chronotherapy: Final efficacy update at 7 years of flat vs chronomodulated infusion (chrono) of oxaliplatin, 5-fluorouracil and leucovorin as first line treatment of metastatic colorectal cancer
8. Towards chronotherapy of neoplasia. Tolerance to treatment depends upon host rhythms
9. Circadian rhythms in drinking behaviour and locomotor activity of rats are eliminated by hypothalamic lesions
10. Transplanted suprachiasmatic nucleus determines circadian period
11. Positional cloning of the mouse circadian clock gene
12. Cellular construction of a circadian clock. Period determination in the suprachiasmatic nuclei
13. Decreased nocturnal plasma melatonin peak in patients with estrogen receptor positive breast cancer
14. Stage dependent depression of melatonin in patients with primary breast cancer
15. Depression of serum melatoninin patients with primary breast cancer is not due to an increased peripheral metabolism
16. Diminished pineal function coincides with disturbed circadian endocrine rhythmicity in untreated primary cancer Patients
17. Evidence for modulation of melatonin secretion in men with benign and malignant tumors of the prostate: Relationship with the pituitary hormones
18. Interindividual differences in the circadian hematologic time structure of cancer patients
19. Circadian variation in serum cortisol and circulating neutrophils are markers for circadian variation of bone marrow proliferation in cancer patients
20. Rhythm alteration in patients with metastatic breast cancer and poor prognostic factors
21. Disruption of the circadian patterns of serum cortisol in breast and ovarian cancer patients. Relationships with tumour marker antigens
22. Diurnal cortisol rhythm as a predictor of breast cancer survival
23. Marked 24-h rest/activity rhythms are associated with better quality of life, better response and longer survival in patients with metastatic colorectal cancer and good performance status
24. Practice parameters for the use of actigraphy in the clinical assessment of sleep disorders
25. The role of actigraphy in the evaluation of sleep disorders
26. Direct radioimmunoassay for melatonin in plasma
27. Direct radioimmunoassay for 6-sulfatoxymelatonin in plasma with use of an iodinated tracer
28. The search for hidden periodicities in biological time series revisited
29. Assessment of activity circadian rhythms by wrist actigraphy. Preliminary results in 30 patients with colorectal cancer
30. The difference between activity when in bed and out of bed. I. Healthy subjects and selected patients
31. Methods for cosinor rhythmometry
32. The immune-hypothalamic-pituitary-adrenal system
33. Adrenal circadian system in young and elderly human subjects. A comparative study
34. Chronobiology in hematology and immunology
35. Mathematical model of the human circadian system with two interacting oscillators
36. Persistent T lymphocyte rhythms despite suppressed circadian clock outputs in rats
37. Diurnal variation of TNF in the rat brain
38. Independent photoreceptive circadian clocks throughout Drosophila
39. A serum shock induces circadian gene expression in mammalian tissue culture cells
40. Mutagenesis and mapping of a mouse gene, clock, essential for circadian behavior
41. Light-induced suppression of the rat circadian system